Join Helio Genomics for a hybrid KOL event featuring Mindie H. Nguyen, MD, MAS (Stanford University Medical Center), Lead Principal Investigator for the CLiMB trial, who will review results from the pivotal Clinical Trial Multi-analyte Blood Test (CLiMB) study presented at the European Association for the Study of the Liver (EASL) Congress on June 8, 2024.

CLiMB is a multi-site, prospective study comparing the sensitivity and specificity of Helio’s HelioLiver multi-analyte blood test to ultrasound for detection of hepatocellular carcinoma (HCC) within a population at high risk of HCC due to liver cirrhosis.

A live question and answer session will follow the formal presentation.